Skip to content
GeneQ18038311· pop 8· linked from 3 articles

Also known as LB1, TMAP, se20-10, cytoskeleton associated protein 2

Cytoskeleton-associated protein 2 is a protein that in humans is encoded by the CKAP2 gene.

Gene data

CKAP2
Name
cytoskeleton associated protein 2
Type
protein-coding
Position
52,455,429–52,476,630 (+)
Aliases
LB1, TMAP, se20-10
RefSeq RNA
NM_001098525.3, NM_001286686.2, NM_001286687.2, NM_018204.5, XM_005266344.5
RefSeq protein
NP_001091995.1, NP_001273615.1, NP_001273616.1, NP_060674.3, XP_005266401.1

This gene encodes a cytoskeleton-associated protein that stabalizes microtubules and plays a role in the regulation of cell division. The encoded protein is itself regulated through phosphorylation at multiple serine and threonine residues. There is a pseudogene of this gene on chromosome 14. Alternative splicing results in multiple transcript variations. [provided by RefSeq, Nov 2013].

via MyGene.info

Gene · Ensembl

cytoskeleton associated protein 2

Symbol
CKAP2
Biotype
Protein coding
Organism
Homo sapiens
Location
13:52,455,429-52,476,640
Strand
Forward (+)
Assembly
GRCh38
View on Ensembl →

via Ensembl · EMBL-EBI

Wikidata facts

Show 5 more facts
HomoloGene ID
10070
genomic end
53050763
genomic start
53029564
cytogenetic location
13q14.3
Sources (4)

via Wikidata · CC0

~1 min read

Article

3 sections
Contents
  • References
  • External links
  • Further reading

Cytoskeleton-associated protein 2 is a protein that in humans is encoded by the CKAP2 gene.

Human CKAP2 gene, the cDNA of which is known as LB1, is a cytoskeleton-associated protein involved in mitotic progression. Its high transcriptional activity has been observed in the testes, thymus, and diffuse B-cell lymphomas. The gene codes for a protein of 683 residues, which lacks a homology to known amino acid sequences. On evidence of immunofluorescence analysis, the CKAP2 product is a cytoplasmic protein associated with cytoskeletal fibrils. The CKAP2 gene is in chromosome 13q14. Rearrangements of this region result in various tumors. Thus deletions have been detected in multiple myeloma, prostate cancer, head-and-neck squamous-cell carcinoma, B-cell prolymphocytic leukemia, non-Hodgkin lymphoma, and in more than half cases of B-cell chronic lymphocytic leukemia.

Available in 8 languages

via Wikidata sitelinks · CC0

Connections

Categories